STERIS plc (NYSE:STE) Shares Acquired by Fenimore Asset Management Inc

Fenimore Asset Management Inc raised its stake in STERIS plc (NYSE:STE) by 0.6% during the 4th quarter, HoldingsChannel reports. The firm owned 254,510 shares of the medical equipment provider’s stock after acquiring an additional 1,528 shares during the quarter. Fenimore Asset Management Inc’s holdings in STERIS were worth $52,317,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Ashton Thomas Securities LLC acquired a new stake in shares of STERIS in the third quarter valued at about $25,000. Central Pacific Bank Trust Division acquired a new stake in STERIS in the third quarter valued at approximately $28,000. Quarry LP purchased a new stake in shares of STERIS during the third quarter valued at approximately $67,000. Asset Dedication LLC lifted its position in shares of STERIS by 54.8% during the third quarter. Asset Dedication LLC now owns 291 shares of the medical equipment provider’s stock worth $71,000 after purchasing an additional 103 shares in the last quarter. Finally, EverSource Wealth Advisors LLC boosted its stake in shares of STERIS by 45.0% in the second quarter. EverSource Wealth Advisors LLC now owns 583 shares of the medical equipment provider’s stock valued at $139,000 after purchasing an additional 181 shares during the period. Institutional investors and hedge funds own 94.69% of the company’s stock.

Analyst Ratings Changes

STE has been the topic of a number of recent analyst reports. Needham & Company LLC reiterated a “hold” rating on shares of STERIS in a report on Friday, November 8th. StockNews.com cut STERIS from a “strong-buy” rating to a “buy” rating in a research note on Tuesday, October 29th. Stephens restated an “overweight” rating and set a $260.00 price objective on shares of STERIS in a report on Thursday, November 7th. Piper Sandler upgraded STERIS from a “neutral” rating to an “overweight” rating and increased their target price for the company from $230.00 to $260.00 in a research note on Thursday, October 24th. Finally, JMP Securities reissued a “market outperform” rating and set a $265.00 price target on shares of STERIS in a research report on Monday, November 18th. One equities research analyst has rated the stock with a hold rating and five have issued a buy rating to the stock. According to data from MarketBeat, STERIS has an average rating of “Moderate Buy” and an average target price of $262.50.

STERIS Stock Down 0.1 %

Shares of STERIS stock opened at $216.88 on Friday. The business has a 50-day moving average price of $211.46 and a 200 day moving average price of $224.63. STERIS plc has a fifty-two week low of $197.82 and a fifty-two week high of $248.24. The firm has a market cap of $21.41 billion, a P/E ratio of 49.52 and a beta of 0.84. The company has a quick ratio of 1.55, a current ratio of 2.41 and a debt-to-equity ratio of 0.33.

STERIS (NYSE:STE) last issued its quarterly earnings results on Wednesday, November 6th. The medical equipment provider reported $2.14 earnings per share for the quarter, beating analysts’ consensus estimates of $2.12 by $0.02. STERIS had a return on equity of 13.78% and a net margin of 8.02%. The business had revenue of $1.33 billion during the quarter, compared to the consensus estimate of $1.33 billion. During the same period in the previous year, the business earned $2.03 EPS. The business’s quarterly revenue was up 7.3% on a year-over-year basis. On average, sell-side analysts forecast that STERIS plc will post 9.11 earnings per share for the current fiscal year.

STERIS Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Thursday, December 19th. Stockholders of record on Tuesday, November 19th were given a $0.57 dividend. The ex-dividend date was Tuesday, November 19th. This represents a $2.28 dividend on an annualized basis and a dividend yield of 1.05%. STERIS’s payout ratio is currently 52.05%.

Insider Transactions at STERIS

In other news, SVP Cary L. Majors sold 1,682 shares of the stock in a transaction that occurred on Monday, November 25th. The stock was sold at an average price of $217.32, for a total transaction of $365,532.24. Following the sale, the senior vice president now directly owns 11,372 shares in the company, valued at approximately $2,471,363.04. This represents a 12.88 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 1.14% of the company’s stock.

STERIS Company Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.